Genolution Inc. (225220) — Capital Reinvestment Ratio
Latest as of March 2024:
18.57x
Genolution Inc. (225220) has a Capital Reinvestment Ratio of 18.57x as of March 2024, meaning it reinvests 19% of its operating cash flow (₩174.53 Million) in capital expenditures (₩3.24 Billion). See Genolution Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
18.57x
Capex / Operating Cash Flow
Operating Cash Flow
₩174.53 Million
KRW
Capital Expenditures
₩3.24 Billion
KRW
Data as of
Mar 2024
Most recent filing
Genolution Inc. Capital Reinvestment Ratio (2017–2022)
This chart tracks Genolution Inc.'s Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Genolution Inc. (2017–2022)
Year-by-year Capital Reinvestment Ratio for Genolution Inc. from 2017 to 2022. For live market cap and broader valuation context, see Genolution Inc. (225220) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 1.66x | ₩13.55 Billion | ₩22.54 Billion | ▲ +734.3% |
| 2021 | 0.20x | ₩25.73 Billion | ₩5.13 Billion | ▲ +5.6% |
| 2020 | 0.19x | ₩45.97 Billion | ₩8.68 Billion | ▼ -99.0% |
| 2018 | 19.82x | ₩147.49 Million | ₩2.92 Billion | ▲ +1549.9% |
| 2017 | 1.20x | ₩717.13 Million | ₩861.62 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow